T
Takeda
Better Health, Brighter Future
Tokyo, Japan (US: Cambridge, MA)
50,000+
About Takeda
Industry:
Pharmaceuticals
Founded:
1781
Founders:
Chobei Takeda I
Status:
Public (NYSE: TAK)
Funding & Growth
Total Raised:
N/A
Valuation:
$50B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Strong rare disease and GI focus
- • Cambridge, MA location (US hub)
- • Values-driven culture
- • Good work-life balance
- • Growing data science investment
✗ Cons
- • Japanese corporate influence
- • Post-Shire acquisition integration
- • Some timezone challenges with HQ
- • Large company processes